MIRATI THERAPEUTICS INC's ticker is MRTX and the CUSIP is 60468T105. A total of 238 filers reported holding MIRATI THERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.7%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $13,068,000 | -54.6% | 300,000 | -14.3% | 1.74% | -53.3% |
Q1 2022 | $28,777,000 | +292.3% | 350,000 | +600.0% | 3.73% | +393.5% |
Q4 2021 | $7,335,000 | -33.2% | 50,000 | 0.0% | 0.76% | -19.7% |
Q4 2020 | $10,982,000 | +79.2% | 50,000 | -37.3% | 0.94% | -59.6% |
Q1 2020 | $6,127,000 | -92.8% | 79,699 | -88.0% | 2.33% | -88.9% |
Q4 2019 | $85,520,000 | – | 663,660 | – | 21.08% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Aviva Holdings Ltd. | 3,135,966 | $688,784,000 | 67.42% |
Avoro Capital Advisors LLC | 4,535,000 | $996,067,000 | 17.15% |
Darwin Global Management, Ltd. | 260,876 | $57,299,000 | 15.99% |
Boxer Capital, LLC | 1,765,560 | $387,788,000 | 12.46% |
Perceptive Advisors | 3,693,516 | $811,244,000 | 8.71% |
Consonance Capital Management LP | 330,000 | $72,481,000 | 6.77% |
EcoR1 Capital, LLC | 464,298 | $101,978,000 | 5.48% |
Fairmount Funds Management LLC | 60,500 | $13,288,000 | 4.75% |
INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 67,400 | $14,804,000 | 4.04% |
RTW INVESTMENTS, LP | 1,054,364 | $231,581,000 | 3.88% |